Inventor · disambiguated record
Jeffrey M. Smith
Also filed as: SMITH JEFFREY · SMITH JEFFREY M
4 granted patents·3 pending applications·163 citations·filing 2011–2022
76Inventor score
Top patents by PatentIndex Score
7 records- 0196US9102671B2Compounds and compositions as TRK inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Aug 11, 2015·80 cites·19 claims
- 0293US8637516B2Compounds and compositions as TRK inhibitorsFAN YI·Filed 2011·Granted Jan 28, 2014·82 cites·29 claims
- 0368US11384078B25,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2018·Granted Jul 12, 2022·1 cites·20 claims
- 0462US2022340573A11,2,4-oxadiazole derivatives as liver x receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0560US2022324863A15,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseasesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0659US11427586B21,2,4-oxadiazole derivatives as liver X receptor agonistsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·21 claims
- 0755US2024238305A1Formulations of 3-((3-(4-(2-(isobutylsulfonyl)phenoxy)-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-5-yl)methyl)-5,5-dimethyl-1-(2-morpholinoethyl)imidazolidine-2,4-dioneNOVARTIS AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey M. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →